#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.
RSS   Newsletter   Contact   Advertise with us

Arcadia Bio appoints Matthew Plavan as CFO

Share on Twitter Share on LinkedIn
Staff Writer | Davis, Ca., USA | September 12, 2016
Arcadia BioSeptember 12, 2016, Davis, Ca., USA - Arcadia Biosciences, Inc., an agricultural technology company, announced that Matthew T. Plavan will join the company’s executive team as chief financial officer on September 12, 2016.
Mr. Plavan brings nearly 30 years of financial and executive leadership experience to Arcadia in the areas of business operations, fiscal management and strategy, commercial partnering, M&A and integration activities, and public and private equity fundraising.

Most recently, Mr. Plavan served in multiple executive capacities, including CFO, COO and CEO with Cesca Therapeutics, Inc., a company engaged in research, development and commercialization of autologous cell-based therapeutics.

Prior to Cesca, he served as CFO with venture and private equity-backed technology companies, including Strion Air, Inc. and Reason, Inc.

He also held executive finance positions with McKesson Corporation and audit and advisory management positions with Ernst & Young.

Mr. Plavan is a certified public accountant and earned a B.A. in business economics from the University of California, Santa Barbara.

Steve Brandwein, Arcadia’s VP of finance and administration, who has been serving as interim CFO, will be retiring from the company as soon as an orderly transition is complete.